首页> 外文OA文献 >A randomized phase II trial assessing in advanced non-small cell lung cancer patients with stable disease after two courses of cisplatin-gemcitabine an early modification of chemotherapy doublet with paclitaxel-gemcitabine versus continuation of cisplatin-gemcitabine chemotherapy (GFPC 03-01 Study).

【2h】

A randomized phase II trial assessing in advanced non-small cell lung cancer patients with stable disease after two courses of cisplatin-gemcitabine an early modification of chemotherapy doublet with paclitaxel-gemcitabine versus continuation of cisplatin-gemcitabine chemotherapy (GFPC 03-01 Study).

机译：一项随机II期临床试验中晚期非小细胞肺癌患者与评估后病情不稳定与双药化疗的顺铂，吉西他滨今年年初变化两场比赛紫杉醇，吉西他滨与（03-01 GFpC研究）化疗吉西他滨联合顺铂延续。

页面导航

摘要
著录项
相似文献
相关主题

摘要

International audience

机译：国际观众

著录项

作者
Vergnenègre Alain; Tillon Julie; Corre Romain; Barlési Fabrice; Berard Henri; Vernejoux Jean-Marc; Le Caer Hervé; Fournel Pierre; Marin Benoît; Chouaïd Christos;
展开▼
作者单位

展开▼
年度 2009
总页数
原文格式 PDF
正文语种 eng
中图分类
入库时间 2022-08-20 21:11:07

相似文献

外文文献
中文文献
专利

1. 来自一项艾日布林联合吉西他滨对比紫杉醇联合吉西他滨作为HER2阴性转移性乳腺癌的一线化疗的II期、多中心、随机试验的包含神经病变相关量表的生活质量结果:韩国癌症研究组试验(KCSG BR13-11) [J] . Ji-Yeon Kim, Young-Hyuck Im, Tae-Yong Kim, 癌症（英文版） . 2019,第008期
2. A randomized phase II trial assessing in advanced non-small cell lung cancer patients with stable disease after two courses of cisplatin-gemcitabine an early modification of chemotherapy doublet with paclitaxel-gemcitabine versus continuation of cisplatin-gemcitabine chemotherapy (GFPC 03-01 Study). [J] . Vergnenegre A, Tillon J, Corre R, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2009,第3期

机译：一项II期随机临床试验，评估了在接受两个疗程的顺铂-吉西他滨，紫杉醇-吉西他滨对化疗的双重治疗和顺铂-吉西他滨的持续治疗后，病情稳定的晚期非小细胞肺癌患者（GFPC 03-01研究）。
3. Randomized, phase III study of gemcitabine or erlotinib maintenance therapy versus observation,with predefined second-line treatment, after cisplatin-gemcitabine induction chemotherapy in advanced non-small-cell lung cancer [J] . PérolM., ChouaidC., PérolD., Journal of Clinical Oncology . 2012,第28期

机译：吉西他滨或厄洛替尼维持治疗与观察与随机二线治疗的随机，III期研究在晚期非小细胞肺癌顺铂-吉西他滨诱导化疗后的应用
4. Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group. [J] . Fossella FV, DeVore R, Kerr RN, Journal of Clinical Oncology . 2000,第12期

机译：多西他赛与长春瑞滨或异环磷酰胺在之前接受过含铂化疗方案治疗的晚期非小细胞肺癌患者中的随机III期试验。 TAX 320非小细胞肺癌研究组。
5. Pemetrexed versus docetaxel single agent chemotherapy in chemotherapy-naive elderly patients with advanced non-small cell lung cancer [C] . Hua Xin, Zhenguo Han, Haibo Huang 2011 International Conference on Human Health and Biomedical Engineering . 2011

机译：培美曲塞与多西他赛单药化疗在未接受化疗的老年晚期非小细胞肺癌患者中的作用
6. Assessing the effectiveness of palliative chemotherapy for non-small cell lung cancer: A phase IV study of patients treated at Ontario's cancer centres [D] . Harrison, Lyndsay Dawn. 2012

机译：评估姑息化疗对非小细胞肺癌的有效性：在安大略省癌症中心接受治疗的患者的IV期研究
7. Docetaxel maintenance therapy versus best supportive care after first-line chemotherapy with different dose docetaxel plus cisplatin for advanced non-small cell lung cancer (TFINE study CTONG-0904): an open-label randomized phase III trial [O] . Li Zhang, Shun Lu, Ying Cheng, 2021

机译：多西紫杉醇维护治疗与不同剂量DOCETAXEL加顺铂的先进非小细胞肺癌（TFINE-0904）：开放标签随机第三阶段试验
8. A randomized phase II trial assessing in advanced non-small cell lung cancer patients with stable disease after two courses of cisplatin-gemcitabine an early modification of chemotherapy doublet with paclitaxel-gemcitabine versus continuation of cisplatin-gemcitabine chemotherapy (GFPC 03-01 Study). [O] . Vergnenègre Alain, Tillon Julie, Corre Romain, 2009

机译：一项II期随机临床试验，评估了在接受两个疗程的顺铂-吉西他滨，紫杉醇-吉西他滨对化疗双重治疗的早期改良与继续进行顺铂-吉西他滨化疗之后的稳定疾病的晚期非小细胞肺癌患者（GFPC 03-01研究）。

摘要

著录项

相似文献

相关主题

期刊订阅